Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Envveno Medical Corporation currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 2 distinct art units, which indicates that the company is pursuing patent protection in multiple specialized technical fields. This distribution requires the applicant to manage the specific requirements of 2 different administrative units within the patent office.
The prosecution of these matters involves 2 distinct examiners, with each examiner handling one of the pending actions. This structure means that there is no overlap in the individuals reviewing the company's current applications, requiring separate strategies for each case. The use of 2 distinct examiners suggests a diverse range of technical subject matter that necessitates different areas of examiner expertise.
COCHRAN, KARI LEE is identified as the busiest examiner for the portfolio, with 1 busiest examiner pending action. Although this individual is the busiest, they are only responsible for 1 of the 2 total pending office actions. The remaining action is handled by another examiner, ensuring that the company's pending workload is evenly split across the 2 distinct examiners currently engaged with the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COCHRAN, KARI LEE | 1 | 100.0% | +0.0% |
| TRAN, JULIE THI | 1 | 33.3% | +70.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18196142 | TRANSCATHETER VEIN FRAME FOR VENOUS INSUFFICIENCY | COCHRAN, KARI LEE | — |
| 17507607 | BIOPROSTHETIC GRAFT FOR CORONARY ARTERY BYPASS GRAFTING | TRAN, JULIE THI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17507607 | BIOPROSTHETIC GRAFT FOR CORONARY ARTERY BYPASS GRAFTING | TRAN, JULIE THI | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18196142 | TRANSCATHETER VEIN FRAME FOR VENOUS INSUFFICIENCY | COCHRAN, KARI LEE | 3774 | §102§103 | Non-Final OA | — | Pending | May 11, 2023 |
| 17507607 | BIOPROSTHETIC GRAFT FOR CORONARY ARTERY BYPASS GRAFTING | TRAN, JULIE THI | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial